(Q35000368)

5 August 2017

1 reference

title

Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects (English)

1 reference

attention deficit hyperactivity disorder

5 August 2017

1 reference

1 reference

Mark D Rapport

1

1 reference

PubMed ID

12436807

5 August 2017

Catherine Moffitt

series ordinal

2

1 reference

5 August 2017

1 November 2002

1 reference

Clinical Psychology Review

5 August 2017

1 reference

5 August 2017

22

1 reference

5 August 2017

1107-1131

1 reference

5 August 2017

8

1 reference

Recurrent limb pain in schoolchildren.

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

The covariation of common psychosomatic symptoms among children from socio-economically differing residential areas. An epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Cardiovascular responses of hyperactive children to methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

A review of stimulant drug research with hyperactive children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

The effects of methylphenidate on various types of activity level and attention in hyperkinetic children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Hyperkinesis, autonomic nervous system activity and stimulant drug effects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Developmental changes in the mother-child interactions of hyperactive boys: effects of two dose levels of Ritalin.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Effects of methylphenidate on cardiovascular responses in attention deficit hyperactivity disordered adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Somatization in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Pemoline, methylphenidate, and placebo in children with minimal brain dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

A dose-response analysis of the effects of methylphenidate on the peer interactions and simulated classroom performance of ADD children with and without conduct problems.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

A developmental dose-response analysis of the effects of methylphenidate on the peer interactions of attention deficit disordered boys.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Does methylphenidate normalize the classroom performance of children with attention deficit disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Headaches and psychopathology in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Somatic complaints and psychopathology in children and adolescents: stomach aches, musculoskeletal pains, and headaches

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Drug and placebo side effects in methylphenidate-placebo trial for attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Blood pressure and pulse changes in hyperactive children treated with imipramine and methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Prolactin, growth hormone and growth responses in boys with attention deficit disorder and hyperactivity treated with methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Stimulant effects on cooperation and social interaction between hyperactive children and their mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Methylphenidate and growth in hyperactive children. A controlled withdrawal study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Prevalence of pain combinations and overall pain: a study of headache, stomach pain and back pain among school-children.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Differential effectiveness of methylphenidate and Adderall in school-age youths with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Growth of hyperactive children on maintenance regimen of methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Growth of hyperactive children treated with methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Effects of methylphenidate on preschool children with ADHD: cognitive and behavioral functions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Methylphenidate and baseball playing in ADHD children: who's on first?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Attention-Deficit/Hyperactivity Disorder and methylphenidate: a dose-response analysis and parent-child comparison of somatic complaints

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Relative cardiovascular safety of psychostimulants used to treat attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Depression of Growth in Hyperactive Children on Stimulant Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Growth of Hyperactive Children Treated With Methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Dosage effects of methylphenidate on the social behavior of adolescents diagnosed with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

A dose-response and time-action analysis of autonomic and behavioral effects of methylphenidate in attention deficit disorder with hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Methylphenidate in Hyperkinetic Children: Differences in Dose Effects on Learning and Social Behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Methylphenidate oral dose plasma concentrations and behavioral response in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

Does stimulant medication improve the peer status of hyperactive children?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2802%2900129-0

7 January 2021

10.1016/S0272-7358(02)00129-0

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12436807